• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡聚糖凝胶/透明质酸钙化在一名曾接受膀胱输尿管反流治疗的患者中伪装成远端输尿管结石。

Dextranomer/Hyaluronic Acid Calcification Masquerading as Distal Ureteral Calculi in a Patient Previously Treated for Vesicoureteral Reflux.

作者信息

Bozkurt Muammer, Agalarov Samir, Merder Erkan, Altunrende Fatih

机构信息

Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.

出版信息

J Endourol Case Rep. 2018 Apr 1;4(1):51-52. doi: 10.1089/cren.2017.0051. eCollection 2018.

DOI:10.1089/cren.2017.0051
PMID:29675477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5905864/
Abstract

Subureteral endoscopic injection is a safe and effective treatment for vesicoureteral reflux (VUR). Dextranomer/hyaluronic acid (Dx/HA) is the most commonly used bulking agent for the treatment of VUR. We report a confusing radiographic finding of calcified Dx/HA injection initially simulates distal ureteral stone in a female patient who has intermittent lumbar pain. Calcification of Dx/HA implants may mimic distal ureteral calculi; therefore, urologists should be aware of the potentially confusing radiographic images.

摘要

输尿管下内镜注射是治疗膀胱输尿管反流(VUR)的一种安全有效的方法。葡聚糖omer/透明质酸(Dx/HA)是治疗VUR最常用的填充剂。我们报告了一例令人困惑的影像学表现,在一名间歇性腰痛的女性患者中,钙化的Dx/HA注射最初模拟了远端输尿管结石。Dx/HA植入物的钙化可能会模仿远端输尿管结石;因此,泌尿外科医生应注意可能令人困惑的影像学图像。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673d/5905864/a68c96f21853/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673d/5905864/fb03a2037832/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673d/5905864/a68c96f21853/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673d/5905864/fb03a2037832/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673d/5905864/a68c96f21853/fig-2.jpg

相似文献

1
Dextranomer/Hyaluronic Acid Calcification Masquerading as Distal Ureteral Calculi in a Patient Previously Treated for Vesicoureteral Reflux.葡聚糖凝胶/透明质酸钙化在一名曾接受膀胱输尿管反流治疗的患者中伪装成远端输尿管结石。
J Endourol Case Rep. 2018 Apr 1;4(1):51-52. doi: 10.1089/cren.2017.0051. eCollection 2018.
2
Dextranomer/hyaluronic acid copolymer (Deflux) implants mimicking distal ureteral calculi on CT.
Pediatr Radiol. 2008 Jan;38(1):104-6. doi: 10.1007/s00247-007-0613-z. Epub 2007 Oct 5.
3
Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.小儿原发性膀胱输尿管反流的气膀胱镜输尿管再植术与内镜下注射葡聚糖/透明质酸的手术结果分析:一项多中心12年回顾研究
J Laparoendosc Adv Surg Tech A. 2018 Mar;28(3):348-353. doi: 10.1089/lap.2017.0281. Epub 2017 Dec 22.
4
Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).聚丙烯酸-聚醇共聚物(PPC)与葡聚糖-透明质酸共聚物(Dx/HA)作为内镜治疗原发性膀胱输尿管反流(VUR)的膨胀剂的随机临床试验。
World J Urol. 2018 Oct;36(10):1651-1656. doi: 10.1007/s00345-018-2314-7. Epub 2018 May 3.
5
Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.内镜注射葡聚糖omer/透明质酸共聚物微创治疗膀胱输尿管反流:亚特兰大儿童医院的经验。
J Urol. 2003 Jul;170(1):211-5. doi: 10.1097/01.ju.0000072523.43060.a0.
6
The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.两种不同填充剂(葡聚糖-透明质酸共聚物和聚丙烯酸-多元醇共聚物)治疗原发性膀胱输尿管反流的疗效
Int Braz J Urol. 2016 May-Jun;42(3):514-20. doi: 10.1590/S1677-5538.IBJU.2015.0274.
7
Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.两种填充剂用于儿童IV级和V级膀胱输尿管反流的内镜治疗:葡聚糖硫酸钠-透明质酸共聚物与聚丙烯酸多元醇共聚物的比较
J Pediatr Surg. 2016 Oct;51(10):1711-5. doi: 10.1016/j.jpedsurg.2016.03.013. Epub 2016 Apr 9.
8
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.用葡聚糖-透明质酸进行内镜治疗膀胱输尿管反流:组织学结果
J Urol. 2003 Mar;169(3):1109-13. doi: 10.1097/01.ju.0000053013.49676.89.
9
Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.右旋糖酐/透明质酸(Dx/HA)注射治疗原发性膀胱输尿管反流后的长期临床结局及家长满意度
Front Pediatr. 2019 Sep 27;7:392. doi: 10.3389/fped.2019.00392. eCollection 2019.
10
Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? ureteroneocystostomy 术后和下尿路注射葡聚糖/透明质酸治疗膀胱输尿管反流并发发热性尿路感染——手术方法和成功率重要吗?
J Urol. 2013 Jan;189(1):275-82. doi: 10.1016/j.juro.2012.09.011. Epub 2012 Nov 20.

引用本文的文献

1
Late Calcification Following Endoscopic Treatment of Reflux Masquerading as a Distal Ureteric Calculus.内镜治疗反流伪装成远端输尿管结石后的晚期钙化
J Indian Assoc Pediatr Surg. 2023 Nov-Dec;28(6):548. doi: 10.4103/jiaps.jiaps_165_23. Epub 2023 Nov 2.

本文引用的文献

1
Incidence of Deflux® calcification masquerading as distal ureteric calculi on ultrasound.超声下反流 ® 钙化表现为远端输尿管结石的发生率。
J Pediatr Urol. 2013 Dec;9(6 Pt A):820-4. doi: 10.1016/j.jpurol.2012.10.025. Epub 2012 Nov 24.
2
Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children.儿童膀胱输尿管反流内镜治疗后葡聚糖凝胶/透明质酸共聚物植入物在计算机断层扫描上的表现
J Urol. 2009 Mar;181(3):1324-8; discussion 1329. doi: 10.1016/j.juro.2008.11.036. Epub 2009 Jan 20.
3
Calcification in a Deflux bleb thought to be a ureteral calculus in a child.
J Pediatr Urol. 2008 Feb;4(1):88-9. doi: 10.1016/j.jpurol.2007.02.005. Epub 2007 Apr 20.
4
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.用葡聚糖-透明质酸进行内镜治疗膀胱输尿管反流:组织学结果
J Urol. 2003 Mar;169(3):1109-13. doi: 10.1097/01.ju.0000053013.49676.89.